CompaniesSeneca Biopharmaceuticals

Seneca Biopharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

0

As Collaborator

5

Total Enrollment

2,322

By Phase

PHASE1: 3EARLY_PHASE1: 1PHASE3: 1

By Status

COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details

Recent Trials

NCT06353152Collaborator
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma
PHASE1Recruiting
12 participants
Started: Nov 17, 2023 · Completed: Nov 16, 2025
NCT03966040Collaborator
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
PHASE1Completed
144 participants
Started: May 16, 2019 · Completed: May 16, 2020
NCT02804711Collaborator
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
PHASE1Completed
144 participants
Started: Sep 30, 2016 · Completed: Sep 30, 2017
NCT02820883Collaborator
A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
EARLY_PHASE1Completed
30 participants
Started: Jun 30, 2016 · Completed: Aug 31, 2016
NCT02692859Collaborator
A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine
PHASE3Completed
1,992 participants
Started: Sep 30, 2013 · Completed: Aug 31, 2014
Related Companies
Leading Biosciences To Become Palisade Bio
merged
Seneca Biopharmaceuticals | Biotech Hunter | Biotech Hunter